1. Olthoff CMG, Schouten JSAG, Bart W, Webbers CAB . Non-compliance with ocular hypertensive treatment in patients with glaucoma or ocular hypertension, an evidence based review. Ophthalmology 2005; 112: 953–960.
2. Ethical Strategies Ltd.. The costs of blindness. An analysis of the costs of visual impairment and blindness in the United Kingdom. [serial online] 2003 [cited 2006 Sept 30]; [1-65]. Available from URL:
http://www.healthyeyes.org.uk/fileadmin/healthy-eyes/downloads/costs-of-blindness.doc
.
3. Mitchell P, Smith W, Attebo K, Healy PT . Prevalence of open angle glaucoma in Australia: the blue mountains study. Ophthalmology 1996; 103: 1661–1669.
4. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW . Compliance barriers in glaucoma: a systematic classification. J Glaucoma 2003; 12: 393–398.
5. Quigley H, Goldberg I, Kitazawa Y, Halprin R, Hitchings R, Gross R et al. Cooperation with medical therapy, report from the global AIGS committee on cooperation with therapy. In: Greve EL (ed). International Glaucoma Review, Supplement 2006, vol. 7. Kugler Publications: The Netherlands, 2006, pp 354–359.